Search by Drug Name or NDC

    NDC 00187-2098-10 Arazlo 0.45 mg/g Details

    Arazlo 0.45 mg/g

    Arazlo is a TOPICAL LOTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bausch Health US, LLC. The primary component is TAZAROTENE.

    Product Information

    NDC 00187-2098
    Product ID 0187-2098_06456968-fe83-2c27-e063-6294a90af3ea
    Associated GPIs 90050027004120
    GCN Sequence Number 080595
    GCN Sequence Number Description tazarotene LOTION 0.045 % TOPICAL
    HIC3 L9H
    HIC3 Description TOPICAL ACNE AGENT,RETINOIC ACID RECEPTOR AGONIST
    GCN 47488
    HICL Sequence Number 013315
    HICL Sequence Number Description TAZAROTENE
    Brand/Generic Brand
    Proprietary Name Arazlo
    Proprietary Name Suffix n/a
    Non-Proprietary Name tazarotene
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form LOTION
    Route TOPICAL
    Active Ingredient Strength 0.45
    Active Ingredient Units mg/g
    Substance Name TAZAROTENE
    Labeler Name Bausch Health US, LLC
    Pharmaceutical Class Retinoid [EPC], Retinoids [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA211882
    Listing Certified Through 2024-12-31

    Package

    NDC 00187-2098-10 (00187209810)

    NDC Package Code 0187-2098-10
    Billing NDC 00187209810
    Package 10 TUBE in 1 CARTON (0187-2098-10) / 3 g in 1 TUBE (0187-2098-03)
    Marketing Start Date 2019-12-19
    NDC Exclude Flag N
    Pricing Information N/A